Blindness is an uncommon but devastating complication of tuberculosis meningitis. The main causes are chronically raised intracranial pressure (hydrocephalus and/or tuberculomas) or direct involvement of the optic chiasm or optic nerves by the basal arachnoiditis (inflammation and/or compression). Antituberculosis therapy combined with corticosteroids and control of intracranial pressure constitutes the mainstay of therapy for tuberculous meningitis. Despite these treatment measures, some patients develop blindness, mainly as a result of progressive optochiasmatic arachnoiditis. This led us to explore the role of adjuvant thalidomide therapy, and we describe the dramatic recovery of vision in 4 consecutive cases. Clinical recovery was accompanied by marked radiological improvement on magnetic resonance imaging (MRI) of the brain.
Schoeman JF, Van Zyl LE, Laubscher JA, Donald PR. Serial CT scanning in childhood tuberculous meningitis: prognostic features in198 cases. J Child Neurol. 1995 ;10(1):320-329.
2.
Afghani B., Lieberman JMParadoxical enlargement or development of intracranial tuberculomas during therapy: case report and review. Clin Infect Dis. 1994;19(6):1092-1099.
3.
Schluger NW, Rom WNThe host immune response to tuberculosis. Am J Respir Crit Care Med.1998;157(3 pt 1):679-691.
4.
Caws M., Thwaites G., Dunstan S., et al. The influence of host and bacterial genotype on the development of disseminated disease with mycobacterium tuberculosis. PLoS Pathog. 2008;4(3): e1000034.
5.
Schoeman JF, Fieggan G., Seller N., Mendelson M., Hartzenberg B.Intractable intracranial tuberculous infection responsive to thalidomide: report of 4 cases. J Child Neurol. 2006;21(4):301-308.
6.
Lorber J.Treatment of tuberculous meningitis. Br Med J. 1960; 1(5182):1309-1312.
7.
Ramachandran RS, Ramanathan K., Indra G.Tuberculous meningitis. A review of 288 cases in children. Indian J Pediatr. 1970; 37(266):85-88.
8.
van Well GTJ , Paes BF, Terwee CB, et al. Twenty years of pediatric tuberculous meningitis: a retrospective cohort study in the western cape of South Africa . Pediatrics. 2009;123(1):e1-e8.
9.
Gillan JC, Purvis RJ, Thomas GWOptic atrophy eight years after tuberculous meningitis. Br Med J.1970;4(5728):156-710.
10.
Damany BJSurgery in tuberculosis meningitis. Prog Pediatr Surg . 1982;15:181-185.
11.
Scott RM, Sonntag VK, Wilcox LM, Adelman LS, Rockel THVisual loss from optochiasmatic arachnoiditis after tuberculous meningitis . Case report. J Neurosurg. 1977;46(4):524-526.
Fruchtman SM , Banerji MATuberculous meningitis; diagnostic problem of visual loss and diabetes insipidus during treatment. N Y State J Med. 1980;80(6):963-965.
14.
Udani PM, Bhat US, Dastur DKTuberculosis of central nervous system. Indian Pediatr . 1973;10(11):647-656.
15.
Leibold JEThe ocular toxicity of ethambutol and its relation to dose. Ann N Y Acad Sci. 1966;135(2):904-909.
16.
Chan KH, Cheung RT, Lee R., Mak W., Ho SLCerebral infarcts complicating tuberculous meningitis. Cerebrovasc Dis. 2005; 19(6):391-395.
17.
Constantini S., Umansky F., Nesher R., Shalit M.Transient blindness following intracranial pressure changes in a hydrocephalic child with a V-P shunt. Childs Nerv Syst. 1987;3(6):379-381.
18.
Sodhi PK, Grover SB, Singh D., et al. Diagnosis of optochiasmic tuberculosis revealed by computed tomography and magnetic resonance imaging. Ann Ophthalmol . 2001;33(3):252-256.
19.
De Lavergne V. , Pierquuin, Helluy JR, Martin J.Complication of meningeal tuberculosis, optochiasmic arachnoiditis; arrest of its development by cortisone used early . Rev Med Nancy.1954;79:134-140.
20.
Gourie-Devi M. , Satish P.Hyaluronidase as an adjuvant in the treatment of cranial arachnoiditis (hydrocephalus and optochiasmatic arachnoiditis) complicating tuberculous meningtis. Acta Neurol Scand.1980;62(6):368-381.
21.
Tsenova L., Sokol K., Freedman, Kaplan G.A combination of thalidomide plus antibiotics protects rabbits from mycobacterial meningitis-associated death. J Infect Dis. 1998;177(6):1563-1572.
22.
Bekker LG, Haslett PA, Maartens G., Steyn L., Kaplan G.Thalidomide-induced antigen-specific immune stimulation in patients with human immunodeficiency virus type I and tuberculosis. J Infect Dis . 2000;181(3):954-965.
23.
Haslett PA, Hanekom WA, Muller G., Kaplan G.Thalidomide and a thalidomide analogue drug costimulate virus-specific CD8+ T cells in vitro. J Infect Dis. 2003; 187(6):946-955.
24.
Walker SL, Waters MF, Lockwood DNThe role of thalidomide in the management of erythema nodosum leprosum . Lepr Rev. 2007;78(3):197-215.
25.
Fu LM, Fu-Liu CSThalidomide and tuberculosis. Int J Tuberc Lung Dis.2002;6(7):569-572.
